[go: up one dir, main page]

DK169324B1 - Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne - Google Patents

Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne Download PDF

Info

Publication number
DK169324B1
DK169324B1 DK376986A DK376986A DK169324B1 DK 169324 B1 DK169324 B1 DK 169324B1 DK 376986 A DK376986 A DK 376986A DK 376986 A DK376986 A DK 376986A DK 169324 B1 DK169324 B1 DK 169324B1
Authority
DK
Denmark
Prior art keywords
compound
formula
compounds
preparation
tert
Prior art date
Application number
DK376986A
Other languages
Danish (da)
English (en)
Other versions
DK376986A (da
DK376986D0 (da
Inventor
Jill Ann Panetta
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK376986D0 publication Critical patent/DK376986D0/da
Publication of DK376986A publication Critical patent/DK376986A/da
Application granted granted Critical
Publication of DK169324B1 publication Critical patent/DK169324B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/16—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/04—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK376986A 1985-08-09 1986-08-07 Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne DK169324B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US76416085A 1985-08-09 1985-08-09
US76416085 1985-08-09
US86948886A 1986-06-02 1986-06-02
US86948886 1986-06-02

Publications (3)

Publication Number Publication Date
DK376986D0 DK376986D0 (da) 1986-08-07
DK376986A DK376986A (da) 1987-02-10
DK169324B1 true DK169324B1 (da) 1994-10-10

Family

ID=27117408

Family Applications (1)

Application Number Title Priority Date Filing Date
DK376986A DK169324B1 (da) 1985-08-09 1986-08-07 Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne

Country Status (24)

Country Link
EP (1) EP0211670B1 (zh)
JP (1) JPH0625182B2 (zh)
KR (1) KR870000889B1 (zh)
CN (1) CN1014891B (zh)
AR (1) AR243173A1 (zh)
AU (1) AU590312B2 (zh)
CA (1) CA1285572C (zh)
CY (1) CY1619A (zh)
DE (1) DE3670951D1 (zh)
DK (1) DK169324B1 (zh)
ES (1) ES2001075A6 (zh)
GR (1) GR862081B (zh)
HK (1) HK94791A (zh)
HU (1) HU196192B (zh)
IE (1) IE58718B1 (zh)
IL (1) IL79648A (zh)
LV (1) LV10866B (zh)
MX (1) MX9203108A (zh)
MY (1) MY102365A (zh)
NZ (1) NZ217126A (zh)
PH (1) PH24517A (zh)
PT (1) PT83152B (zh)
SG (1) SG80391G (zh)
SU (1) SU1516012A3 (zh)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512163D0 (en) * 1985-05-14 1985-06-19 Fujisawa Pharmaceutical Co Oxothiazolidine compound
US5691367A (en) * 1985-08-09 1997-11-25 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US5356917A (en) * 1985-08-09 1994-10-18 Eli Lilly And Company Aryl-substituted rhodanine derivatives
US4897406A (en) * 1987-11-13 1990-01-30 Nisshin Flour Milling Co., Ltd. Rhodanine derivatives and pharmaceutical compositions
US5208250A (en) * 1988-05-25 1993-05-04 Warner-Lambert Company Known and selected novel arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and anti-inflammatory agents
IE940525L (en) * 1988-05-25 1989-11-25 Warner Lambert Co Known and selected novel arylmethylenyl derivatives of¹thiazolidinones, imidazolidinones and oxazolidinones useful¹as antiallergy agents and antiinflammatory agents
US5306822A (en) * 1988-05-25 1994-04-26 Warner-Lambert Company Arylmethylenyl derivatives of oxazolidinone
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
ATE139531T1 (de) * 1989-04-07 1996-07-15 Lilly Co Eli Arylsubstituierte rhodaninderivate
ZA9010041B (en) * 1989-12-21 1992-08-26 Lilly Co Eli Compounds for treating inflammatory bowel disease
US5216002A (en) * 1989-12-21 1993-06-01 Eli Lilly And Company Method of treating inflammatory bowel disease
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
DE69123738T2 (de) * 1990-04-27 1997-07-03 Orion-Yhtymae Oy, Espoo Pharmakologisch aktive catecholderivate
ATE157355T1 (de) * 1991-01-21 1997-09-15 Shionogi & Co 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
US5158966A (en) * 1991-02-22 1992-10-27 The University Of Colorado Foundation, Inc. Method of treating type i diabetes
US5143929A (en) * 1991-05-09 1992-09-01 Warner-Lambert Company 2-substituted thiazolidinone, oxazolidinone, and imidazolidinone derivatives of fenamates as antiinflammatory agents
EP0587377A3 (en) * 1992-09-10 1994-09-21 Lilly Co Eli Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease
ATE135697T1 (de) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivate
ATE196464T1 (de) * 1993-06-23 2000-10-15 Chugai Pharmaceutical Co Ltd Benzol-derivate, verwendbar für ischämische erkrankungen
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5476865A (en) * 1994-07-06 1995-12-19 Eli Lilly And Company Methods of inhibiting bone loss
JPH10512883A (ja) * 1995-01-23 1998-12-08 イーライ・リリー・アンド・カンパニー 多発性硬化症の治療方法
EP0761657B1 (en) * 1995-09-07 2000-05-24 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
CA2255073A1 (en) * 1996-07-11 1998-01-22 Brenda Derae Shivers Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone
US6005142A (en) * 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
AU6330999A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
AU2002953533A0 (en) * 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
DE202006018406U1 (de) 2006-12-05 2008-04-10 Seda S.P.A. Verpackung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1038050B (de) * 1955-11-17 1958-09-04 Farmaceutici Italia S A Soc Verfahren zur Herstellung von 5-(3', 4'-Dioxybenzyliden)-Derivaten heterocyclischer Verbindungen
JPS5740478A (en) * 1980-08-22 1982-03-06 Ono Pharmaceut Co Ltd Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
JPS57130950A (en) * 1981-02-05 1982-08-13 Kanegafuchi Chem Ind Co Ltd 3,5-di-tert-butyl-4-hydroxystyrene derivative and anti- inflammatory, analgesic, antipyretic agent and inhibitor for blood platelet aggregation
JPS5879944A (ja) * 1981-11-09 1983-05-13 Kanegafuchi Chem Ind Co Ltd ３，５−ジ・タ−シヤリ−・ブチルスチレン誘導体及び抗炎症、鎮痛、解熱剤並びに血小板凝集阻害剤
US4636516A (en) * 1981-02-19 1987-01-13 Yamanouchi Pharmaceutical Co., Ltd. 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds

Also Published As

Publication number Publication date
DK376986A (da) 1987-02-10
GR862081B (en) 1986-12-24
JPS6242977A (ja) 1987-02-24
HUT42765A (en) 1987-08-28
AU6097286A (en) 1987-02-12
DE3670951D1 (de) 1990-06-13
HK94791A (en) 1991-11-29
LV10866B (en) 1996-04-20
MX9203108A (es) 1992-07-01
KR870000889B1 (ko) 1987-05-02
LV10866A (lv) 1995-10-20
CN1014891B (zh) 1991-11-27
MY102365A (en) 1992-06-17
HU196192B (en) 1988-10-28
KR870002109A (ko) 1987-03-30
EP0211670A2 (en) 1987-02-25
DK376986D0 (da) 1986-08-07
AU590312B2 (en) 1989-11-02
IL79648A0 (en) 1986-11-30
SU1516012A3 (ru) 1989-10-15
ES2001075A6 (es) 1988-04-16
PT83152A (en) 1986-09-01
JPH0625182B2 (ja) 1994-04-06
AR243173A1 (es) 1993-07-30
PT83152B (pt) 1989-03-30
CN86105036A (zh) 1987-02-04
IL79648A (en) 1991-12-12
PH24517A (en) 1990-07-18
IE58718B1 (en) 1993-11-03
CY1619A (en) 1992-07-10
EP0211670A3 (en) 1987-05-06
NZ217126A (en) 1989-01-27
SG80391G (en) 1991-11-15
EP0211670B1 (en) 1990-05-09
CA1285572C (en) 1991-07-02

Similar Documents

Publication Publication Date Title
DK169324B1 (da) Di-tert-butylphenol-forbindelser, anvendelse af disse til fremstilling af farmaceutiske formuleringer, farmaceutiske formuleringer indeholdende forbindelserne samt fremgangsmåde til fremstilling af forbindelserne
TW313567B (zh)
RU2167152C2 (ru) N-замещенные азагетероциклические карбоновые кислоты или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ ингибирования нейрогенного воспаления
AU779096B2 (en) N-(2-hydroxy-3-(1-piperidinyl)propoxy)pyridine-1-oxide-3- carboximidoyl chloride and its use in the treatment of insulin resistance
JPH0236159A (ja) 化学化合物類
US5696112A (en) Fused heterocyclic azepines as vasopressin antagonists
AU655075B2 (en) N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylamines
EP0391644B1 (en) Aryl-substituted rhodanine derivatives
EP1690858B1 (en) Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
JPH05345722A (ja) アミノアルコールのｎ−アシル誘導体を含む薬剤組成物
US5356917A (en) Aryl-substituted rhodanine derivatives
RU2109293C1 (ru) Способ аналгезии и снятия воспалительной реакции у человека
Keogh et al. Altered growth hormone release in Huntington's chorea.
DE69925270T2 (de) Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten
Gelenberg et al. Galactorrhea and hyperprolactinemia associated with amoxapine therapy: Report of a case
WO2011160597A1 (zh) 一种具有降高血压活性的呋喃香豆素类化合物及其制备方法
KR20000035941A (ko) 무정형 벤조티오펜, 그의 제조 방법 및 용도
RU2014329C1 (ru) 5- {(3,5-бис)1,1-диметилэтил(-4-гидроксифенил)-метил} -4-тиазолидинон, обладающий противовоспалительными и противоартритными свойствами
US4552895A (en) Furo[3,2-b]furan-2-(3H)-ones
JPH09291089A (ja) 新規な５−チアゾリルウラシル誘導体又はその塩
US5691367A (en) Aryl-substituted rhodanine derivatives
Guan et al. Aporphines. 58. N-(2-chloroethyl)[8, 9-2H] norapomorphine, an irreversible ligand for dopamine receptors: synthesis and application
US3761509A (en) N,n{40 -alkylenebis (4-substituted-benzamides)
NO149844B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyltiokarbamyl-formamidin-derivater
FI84828B (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla substituerade 1,8-naftyridinoner.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK